“California is going to make its own insulin,” Newsom said in the video. “The failure of the market is nothing more than the cost of insulin. Many Americans experience out-of-pocket costs of জীবন 300 to $ 500 per month for this life-saving drug. California is taking matters into its own hands. ”
It is not clear when state insulin will be available or how much it will cost. A spokesman for the governor’s office did not immediately respond to a request for comment earlier Friday.
The announcement comes from California when top senators in Congress recently unveiled a bipartisan bill to curb the high cost of insulin, which has been condemned for years by lawyers, doctors and President Biden. Sense. Jean Shaheen (DNH) and Susan Collins (R-Maine) said last month’s bill would set a $ 35 monthly cap for insulin costs for patients with personal insurance as well as those enrolled in Medicare, although it would not be the same protection for uninsured. The bill seeks to make insulin more accessible by cracking down on previous approval requirements that could force insurers to get through to help patients pay for medications.
Senators have unveiled a bipartisan plan to reduce the price of insulin
Senate Majority Leader Charles E. Despite promises to bring the insulin pricing bill to the vote from the count (DN.Y.), the law has faced an ups and downs in passing the chamber, as some Republicans have previously blown the idea of a $ 35 cap. As price control.
More than 37 million Americans have diabetes, according to the Center for Disease Control and Prevention, which accounts for about 11 percent of the U.S. population. Although more than 7 million Americans with diabetes are dependent on insulin every day, according to Yale researchers, some Americans have struggled to bear the rising cost of the drug.
Since diabetics typically use two or three vials of insulin per month, the costs can be as high as 6,000 per year for people without insurance, inadequate coverage, or high discounts. Some of the drug list prices can range from $ 125 to over $ 500. Humalog, a branded insulin drug that costs about $ 21 per dew when Eli Lilly launched it in 1996, was listed in the U.S. at about $ 275 at the end of last year.
A 2019 study published in the medical journal JAMA Internal Medicine found that approximately 1 in 4 people with diabetes avoided the dose or ration they took because of the high cost of the drug. Black, Latinox, and Native American patients are disproportionately affected by high costs because they do not have insurance or a level of insurance to cover prices, research shows.
The push to create its own insulin in California is not the first time that any state or group has tried to make drugs in response to costs.
Colorado Governor Jared Polis (D) signed into law in 2019 to limit insulin co-payments to patients with personal insurance at $ 100 per month. In response to higher costs this year, Civica RX, a nonprofit for a consortium of major U.S. hospitals, said in March it planned to make and sell generic versions of insulin for more than $ 30 per drop and more than $ 55 for five injector-pens. Cartridge Civica RX says it expects to start selling insulin In 2024, once it completes construction of a 140,000-square-foot pharmaceutical plant in Petersburg, Va. – and if it wins licensing from the Food and Drug Administration.
A group of hospitals have plans to reduce the cost of insulin, following a congressional rejection
Newsom signed a ৮ 307 billion state budget on June 30. The budget included a $ 17 billion relief package to give residents an “inflation relief” check of 1,050 to address concerns surrounding the country’s highest average gas price. There will be plans Also defer California sales tax on diesel fuel and provide additional assistance to residents who need help with rent and utility bills, according to lawmakers.
Of all the states, California has the highest number of new diabetes patients, according to the governor’s office. According to the state, ethnic minorities, the elderly, men and the poor are the most affected by diabetes in California.
The governor said in a news release last week that the বা 100 million investment budget for insulin was “to develop and manufacture low-cost biosimilar insulin products to increase insulin availability and purchasing power in California.”
“In California, we know people shouldn’t go into debt for taking life-saving drugs,” Newsom said in the video.